Fuse Medical (OTCMKTS:FZMD) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.
This table compares Fuse Medical and Henry Schein’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
This is a breakdown of current recommendations and price targets for Fuse Medical and Henry Schein, as reported by MarketBeat.
||Strong Buy Ratings
Henry Schein has a consensus price target of $82.72, suggesting a potential downside of 2.29%. Given Henry Schein’s higher possible upside, analysts plainly believe Henry Schein is more favorable than Fuse Medical.
Volatility & Risk
Fuse Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares Fuse Medical and Henry Schein’s gross revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Henry Schein has higher revenue and earnings than Fuse Medical.
Henry Schein beats Fuse Medical on 8 of the 9 factors compared between the two stocks.
Fuse Medical Company Profile
Fuse Medical, Inc. distributes medical devices in the United States. It offers orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; full spinal implants for trauma, degenerative disc disease, and deformity indications; and osteo-biologics and regenerative tissue which include human allografts, substitute bone materials, tendons, and regenerative tissues and fluids. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.
Henry Schein Company Profile
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.
Receive News & Ratings for Fuse Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fuse Medical and related companies with MarketBeat.com's FREE daily email newsletter.